ASP015K
National Institutes of Health
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Abstract 1. Although marked gender differences have been reported for the exposure level of the sulfate metabolite M2 of ASP015K…
Background ASP015K is a novel oral Janus kinase (JAK) inhibitor in development for the treatment of rheumatoid arthritis (RA…
Background ASP015K is an oral Janus kinase (JAK) inhibitor with selectivity for JAK1/3 in development for treatment of rheumatoid…
Background ASP015K is an oral Janus kinase (JAK) inhibitor with moderate selectivity for JAK3, a key enzyme for interleukin-2 (IL…
Background Janus kinase (JAK) enzymes play key roles in cytokine signaling and are important in the pathology of autoimmune…
Background ASP015K is an oral Janus kinase (JAK) inhibitor of JAK1/3 in development for treatment of autoimmune diseases (eg…